---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-131554"
form_type: "8-K"
ticker: "QNRX"
cik: "0001671502"
company_name: "Quoin Pharmaceuticals, Ltd."
filed_at: "2024-12-26T23:59:59+00:00"
generated_at: "2026-05-28T23:19:54.119228+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Quoin Pharmaceuticals prices $6.8M public offering of ADSs and warrants

## Summary
- Gross proceeds ~$6.8M from offering of 15,111,110 ADSs (or pre-funded warrants) and Series F/G warrants at $0.45 per unit.
- Series F warrants (2-yr expiry) and Series G warrants (5-yr expiry) each have exercise price of $0.45 per ADS.
- Prior warrants for up to 7,002,500 ADSs amended: exercise price reduced to $0.45 from $1.60, expiry extended to Dec 2029.
- Company officers and directors purchased ~$600K of ADSs and warrants in the offering.
- Net proceeds to be used for general corporate purposes, including R&D and working capital.

## SEC filing metadata
- accession: 0001104659-24-131554
- form_type: 8-K
- ticker: QNRX
- cik: 0001671502
- company_name: Quoin Pharmaceuticals, Ltd.
- filed_at: 2024-12-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671502/000110465924131554/0001104659-24-131554-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671502/000110465924131554/tm2430640d5_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-131554
- JSON: https://secwatch.observer/filing/0001104659-24-131554.json
- Plain text: https://secwatch.observer/filing/0001104659-24-131554.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.